As of 04 Nov 2026 22:35 UTC. Status is always as stated in the latest recorded notice; the sources do not publish resolution, so nothing on this page says a medicine is back — see methodology.
Presentations, as stated in the latest recorded notice
Each line is re-expressed from MSN/2023/068 (21 Jul 2023): the product named, the status the source stated, and the expected-back phrase kept as written. Not the source's sentence, and not an observation of stock.
| Presentation | Status, as stated | Expected back, as stated | Stated in |
|---|---|---|---|
| Atomoxetine 40mg and 60mg capsulesaffected product · inferred from phrasing | Out of stock, as stated | September 2023precision: a month · window end 30 Sep 2023, derived from “September 2023” | notice of 21 Jul 2023 |
| Other strengths and formulations of atomoxetineclass-level statement by the source, not a named product · inferred from phrasing | Stated as available | — not stated for this line | notice of 21 Jul 2023 |
| Guanfacine (Intuniv®) prolonged release tabletsnamed by the source as remaining available · inferred from phrasing · its own page → | Stated as available | — not stated for this line | notice of 21 Jul 2023 |
Protocol in force
No Serious Shortage Protocol matched to this name is in force on the NHSBSA register. Matching is by name until identifier coding lands.
Named in the source as remaining available
- Guanfacine (Intuniv®) prolonged release tablets — named by the source as remaining available (inferred from phrasing)
Only names the source itself listed, as it listed them (source post ↗). No substitution, dosing or counselling advice is given here or implied.
Identifiers — Atomoxetine
BNF chemical and SNOMED identifiers from NHSBSA Prescription Cost Analysis (Open Government Licence), matched by name (presentation name), confidence 0.90 — grouping under review where marked Release Jul 2026.
BNF SNOMED mapping, NHSBSA Copyright 2026; Prescription Cost Analysis (PCA) Monthly Administrative Data, NHSBSA Copyright 2026. This information is licenced under the terms of the Open Government Licence.
History
One supply notification on record, 21 Jul 2023. We record when a shortage is declared, not when stock returns — the source doesn't publish that. An update sharing a reference counts as one episode.
| Issued | Notice | Kind | Tier | Reference |
|---|---|---|---|---|
| 21 Jul 2023 | Medicine Supply Notification: Atomoxetine 40mg and 60mg capsules | Supply notification | Tier 2 | MSN/2023/068 |
Also recorded under
No other name appears in this medicine's notice titles. Grouping is by the head name in each title; brand and generic names may still sit on separate pages until identifier coding refines it — see the A–Z.
Scotland — separate record
NHS Scotland issues its own Medicine Supply Alert Notices. These match this medicine's name; they are shown beside, never added to, the England record.
- MSAN(2023)13 Atomoxetine 40mg and 60mg capsules · issued 25 Jul 2023 · valid until September 2023, as stated · matched by name PDF ↗